Ollier Michele

CIK 00015036852 companiesGENEVA, V8

SEC Profile

Transactions

Companies

Filings

CIK

0001503685

Recent Transactions

22 trades

Exercise of In-Money
Minerva Neurosciences, Inc.$NERV
Warrant Shares
2016-12-12−202,634→ 0 total
Exercise of In-Money
Minerva Neurosciences, Inc.$NERV
Common Stock
2016-12-12$5.77/sh+202,634→ 4,690,906 total
Sale
Minerva Neurosciences, Inc.$NERV
Common Stock
2016-08-10$10.00/sh−1,000,000→ 4,488,272 total
Purchase
Minerva Neurosciences, Inc.$NERV
Common Stock
2015-03-18$4.81/sh+202,634→ 5,488,272 total
Purchase
Minerva Neurosciences, Inc.$NERV
Warrant Shares
2015-03-18$0.13/sh+202,634→ 202,634 total
Purchase
Minerva Neurosciences, Inc.$NERV
Common Stock
2014-07-07$6.00/sh+1,287,500→ 4,952,305 total
Conversion
Minerva Neurosciences, Inc.$NERV
Common Stock
2014-07-07$6.00/sh+114,077→ 3,602,883 total
Conversion
Minerva Neurosciences, Inc.$NERV
Convertible Promissory Note
2014-07-07$6.00/sh−114,077→ 0 total
Conversion
Minerva Neurosciences, Inc.$NERV
Common Stock
2014-07-07$6.00/sh+61,922→ 3,664,805 total
Purchase
Minerva Neurosciences, Inc.$NERV
Common Stock
2014-07-07$6.00/sh+333,333→ 5,285,638 total
Conversion
Minerva Neurosciences, Inc.$NERV
Convertible Promissory Note
2014-07-07$6.00/sh−61,922→ 0 total
Sale
Aegerion Pharmaceuticals, Inc.
Common Stock
2011-07-29$14.61/sh−36,788→ 2,131,827 total
Sale
Aegerion Pharmaceuticals, Inc.
Common Stock
2011-06-29$14.61/sh−877,723→ 2,168,435 total
Award
Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
2011-06-01−9,988→ 9,988 total
Conversion
Aegerion Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2010-10-27−782,801→ 0 total
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27+1,367,346→ 1,371,518 total
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27$7.60/sh+881,128→ 2,730,369 total
Conversion
Aegerion Pharmaceuticals, Inc.
Series A Convertible Preferred Stock
2010-10-27−3,533,095→ 0 total
Purchase
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27$9.50/sh+315,789→ 3,046,158 total
Conversion
Aegerion Pharmaceuticals, Inc.
Senior Subordinated Convertible Promissory Notes
2010-10-27
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27+477,723→ 1,849,241 total
Award
Aegerion Pharmaceuticals, Inc.
Senior Subordinated Convertible Promissory Notes
2010-10-21

Companies

Recent Filings

Address

C/O INDEX VENTURES 2 RUE DE JARGONNANT

GENEVA, V8, 1207

View on SEC.gov